| Literature DB >> 24106574 |
Adino Desale1, Bineyam Taye, Getachew Belay, Alemayehu Nigatu.
Abstract
INTRODUCTION: Logistics management information system for health commodities remained poorly implemented in most of developing countries. To assess the status of laboratory logistics management information system for HIV/AIDS and tuberculosis laboratory commodities in public health facilities in Addis Ababa.Entities:
Keywords: Logistics management information system; laboratory commodities; stock outs
Mesh:
Year: 2013 PMID: 24106574 PMCID: PMC3786148 DOI: 10.11604/pamj.2013.15.46.1969
Source DB: PubMed Journal: Pan Afr Med J
Characteristics of study participants involved in the assessment of laboratory LMIS for ART monitoring and TB laboratory commodities in Addis Ababa, 2010
| Variable | No | % |
|---|---|---|
| Facility | ||
| Hospital | 8 | 18.6 |
| Health center | 24 | 55.8 |
| Regional Laboratory | 1 | 2.3 |
| Regional Health Bureau | 1 | 2.3 |
| Sub-city | 9 | 20.9 |
| Total |
|
|
| Professionals | ||
| Pharmacy co-ordinators | 33 | 28.9 |
| Pharmacy store managers | 33 | 28.9 |
| Sub-city | 9 | 7.9 |
| Laboratory managers | 33 | 28.9 |
| Laboratory mini-store managers | 6 | 5.4 |
| Total |
|
|
Sub-city = sub-city pharmaceutical supply assuring sustainability case team
Sub-city = sub-city pharmaceutical supply assuring sustainability case team leader
Training of pharmacy and laboratory professionals in LMIS by facility type
| Facility type trained | Pharmacy professionals trained | Laboratory professionals |
|---|---|---|
| Hospitals | 14(12.3%) | 3 (2.6%) |
| Health centers | 42 (36.8%) | 0 (0%) |
| Sub-cities | 9 (7.9%) | ___ |
| AARL | ____ | 1(0.9%) |
| AARHB | 2 (1.8) | ____ |
|
| 67 (58.8%) | 4 (3.5%) |
Sub-cities sub-city pharmaceutical supply assuring sustainability case team
__ Respective personnel not available in those facilities
Percentage of facilities that had stock on hand below, above and within the minimum/maximum stock levels on the day of visit on Addis Ababa, 2010
| Commodities | Facilities with less than the minimum stock level n (%) | Facilities with higher than the maximum stock level n(%) | Facilities within the minimum-maximum stock level n (%) | Median months of stock on hand (25th-75th percentile) |
|---|---|---|---|---|
| CD4 Reagent | 6 (75) | 0 (0%) | 2 (25%) | 1.0 (1.0-1.75) |
| FACS flow | 4 (50) | 0 (0%) | 4 (50%) | 1.0 (0.625-1.75) |
| ALP | 3 (37.5%) | 2 (25%) | 3 (37.5%) | 1.5 (1.0-4.25) |
| GPT | 3 (37.5%) | 2 (25%) | 3 (37.5%) | 2.0 (1.0-4.25) |
| GOT | 2 (25%) | 2(25%) | 4 (50%) | 1.5 (1.0-4.5) |
| Bilirubin (Direct) | 6 (75%) | 0 (0%) | 2 (25%) | 0.75 (0.5-1.75) |
| Bilirubin (Total) | 6 (75%) | 0 (0%) | 2 (25%) | 0.75 (0.5-1.00) |
| BUN | 3 (37.5%) | 1 (12.5%) | 4 (50%) | 1.0 (0.625-1.75) |
| Creatinine | 2 (25%) | 0 (0%) | 6 (75%) | 2.0 (1.00-2.00) |
| Glucose | 1 (12.5%) | 1 (12.5%) | 6 (75%) | 1.0 (0.625-2.0) |
| Cell Dyne Lyze | 3 37.5%) | 0 (0%) | 5 (62.5%) | 1.0 (0.625-1.75) |
| Cell Dyne Detergent | 3 37.5%) | 0 (0%) | 5 (62.5%) | 1.0 (0.625-1.75) |
| Cell Dyne Diluent | 2 (25%) | 0 (0%) | 6 (75%) | 1.0 (0.5-1.75) |
| KHB | 15 (45.5%) | 2 (6%) | 16 (48.5%) | 2.0 (1.0-2.0) |
| Stat-pack | 10 (30.3%) | 5 (15%) | 18 (54.5%) | 1.0 (1.0-2.0) |
| Uni-gold | 7 (21.2%) | 12 (36.4%) | 14 (42.4%) | 1.0 (1.0-2.5) |
| Vacutainer Tube | 15 (60%) | 6 (24%) | 4 (16%) | 2.0 (1.0-2.0) |
| Vacutainer Tube | 12 (48%) | 5 (20%) | 8 (32%) | 2.0 (1.0-2.0) |
| Vacutainer N | 15 (60%) | 5 (20%) | 5 (20%) | 1.0 (1.0-2.0) |
| Carbon fuchsin | 10 (29.4%) | 8 (23.5%) | 16 (47%) | 1.0 (1.0-2.0) |
| Methylene blue | 10 (29.4%) | 8 (23.5%) | 16 (47%) | 1.0 (1.0-2.0) |
| Acid alcohol | 15 (44.1%) | 6 (17.6%) | 13 (338%) | (0.5-2.0) |
Vacutainer tube (4ml)
Vacutainer tube (10ml), vacutainer N- vacutainer needle
*For CD4, Hematology and Chemistry reagents number of facilities that manage them (n = 8)
*For Rapid test kits (n= 33), for sample transfer kits (n = 25), for TB reagent (n = 34)
Percentage of facilities stock out for laboratory commodities on the day of visit, reported stock outs during the last 6 months, average duration of stock outs and mean number of stock outs in the last 6 months, March-September/2010, Addis Ababa
| Commodities | No of Facilities | Facilities stock Out on the day of visit n (%) | Facilities stock out any time in the past months% (n) | Mean # of days (range) of stock outs in the past 6 months | Mean # of times stock outs in the past 6 months |
|---|---|---|---|---|---|
| CD4 reagents | 8 | 1 (12.5%) | 4 (50%) | 6 (1-10) | 3 |
| FACS flow | 8 | 2 (25%) | 2 (25%) | 5 (1-7) | 1 |
| ALP | 8 | 1 (12.5%) | 3 (37.5%) | 40 (10-60) | 2 |
| GPT | 8 | 1 (12.5%) | 3 (37.5%) | 40 (7-60) | 2 |
| GOT | 8 | 1 (12.5%) | 3 (37.5%) | 40 (7-60) | 2 |
| Bilirubin (Direct) | 8 | 4 (50%) | 75 (6) | 73 (15-90) | 2 |
| Bilirubin (Total) | 8 | 4 (50%) | 75 (6) | 73 (15-90) | 2 |
| BUN | 8 | 2 (25%) | 50 (4) | 30 (7-45) | 1 |
| Creatinine | 8 | 2 (25%) | 25 (2) | 21 (5-30) | 2 |
| Glucose | 8 | 2 (25%) | 25 (2) | 15 (5-30) | 1 |
| Cell Dyne lyze | 8 | 2 (25%) | 37.5 (3) | 15 (7-21) | 3 |
| CellDyne detergent | 8 | 2 (25%) | 25 (2) | 15(7-30) | 3 |
| Cell Dyne diluent | 8 | 1 (12.5%) | 37.5 (3) | 15 (3-21) | 3 |
| KHB | 33 | 4 (12%) | 27.3 (9) | 13 (5-20) | 3 |
| Stat-pack | 33 | 0 (0%) | 9 (3) | 3 (5-20) | 1 |
| Uni-gold | 33 | 1 (3%) | 21 (7) | 7 (5-12) | 2 |
| Vacutainer tube (4 ml) | 25 | 10 (40%) | 52 (13) | 5 (3-10) | 3 |
| Vacutainer tube (10ml) | 25 | 10 (40%) | 52 (13) | 5 (2-7) | 3 |
| Vacutainer tube needle | 25 | 12 (48%) | 40 (10) | 6 (5-10) | 3 |
| Carbon fuchsin | 34 | 0 (0%) | 11.8 (4) | 7 (5-15) | 1 |
| Methylene blue | 34 | 0 (0%) | 11.8 (4) | 7 (5-15) | 1 |
| Acid alcohol | 34 | 1 (3%) | 17.8 (6) | 7 (3-10) | 2 |